bf/NASDAQ:VRDN_icon.jpeg

COM:VIRIDIANTHERAPEUTICS

Viridian Therapeutics

  • Stock

USD

Last Close

19.62

22/11 21:00

Market Cap

783.10M

Beta: -

Volume Today

858.39K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
263.09K
-
267.82K
1.80%
183K
31.67%
125.50K
31.42%
32K
74.50%
-3.31M
-
-3.31M
0%
average payables
218.48K
-
332.65K
52.26%
248.50K
25.30%
200.50K
19.32%
532.50K
165.59%
738.50K
38.69%
833.50K
12.86%
883K
5.94%
1.50M
69.82%
8.28M
452.28%
8.24M
0.54%
average receivables
1.09M
-
1.04M
4.91%
741K
28.82%
459K
38.06%
990K
115.69%
740K
25.25%
66K
91.08%
54K
18.18%
225.50K
317.59%
276.50K
22.62%
51K
81.56%
book value per share
161.59
-
597.55
269.79%
289.46
51.56%
-6.78
102.34%
30.02
542.82%
26.02
13.32%
7.54
71.02%
33.75
347.50%
15.75
53.33%
12.31
21.83%
0.01
99.92%
capex per share
-0.38
-
-26.53
6,876.84%
-3.42
87.11%
-0.06
98.18%
-0.19
207.39%
-0.23
17.61%
-0.04
82.17%
-0.01
70.63%
-0.03
140.18%
-0.02
12.41%
-0.00
99.92%
capex to depreciation
-0.03
-
-1.85
5,644.83%
-0.67
63.81%
-0.02
97.63%
-0.80
4,931.82%
-1.58
98.28%
-0.29
81.58%
-0.18
39.75%
-2.82
1,502.82%
-3.13
10.96%
0.08
102.57%
capex to operating cash flow
0.00
-
0.12
2,843.33%
0.02
85.17%
0.00
97.67%
0.01
2,005.09%
0.02
89.81%
0.00
85.95%
0.00
39.46%
0.01
339.07%
0.01
37.15%
0.00
42.59%
capex to revenue
-0.00
-
-0.06
5,473.15%
-0.05
21.29%
-0.00
98.14%
-0.06
6,735.72%
-0.05
13.65%
-0.02
64.52%
-0.04
112.43%
-0.11
185.18%
-0.45
294.28%
-2.86
535.85%
cash per share
16.69
-
510.57
2,958.59%
301.19
41.01%
69.47
76.94%
36.98
46.77%
31.66
14.37%
12.85
59.42%
35.88
179.25%
16.53
53.95%
13.23
19.94%
0.01
99.92%
days of inventory on hand
52.09
-
20.15
61.32%
27.61
37.05%
9.17
66.80%
days payables outstanding
59.93
-
28.70
52.11%
35.73
24.50%
22.78
36.26%
days sales outstanding
84.05
-
91.93
9.37%
56.66
38.36%
57.31
1.15%
132.76
131.63%
1.04
99.21%
8.84
745.93%
55.56
-
21.01
62.18%
debt to assets
0.19
-
0.01
94.79%
0.09
765.98%
0.25
186.49%
0.19
22.95%
0.16
17.65%
0.27
76.26%
0.00
98.74%
0.00
26.36%
0.01
373.42%
0.04
240.92%
debt to equity
0.34
-
0.01
96.12%
0.11
694.92%
-3.21
3,119.86%
0.26
108.04%
0.20
22.15%
0.53
162.80%
0.00
99.28%
0.00
26.92%
0.01
380.45%
0.05
243.45%
dividend yield
0.01
-
earnings yield
-0.08
-
-1.38
1,535.40%
-1.87
35.92%
-3.51
87.37%
-0.13
96.23%
-0.36
176.06%
-2.82
673.45%
-1.90
32.75%
-0.34
82.23%
-0.13
60.29%
-0.00
99.82%
enterprise value
26.14M
-
690.86K
97.36%
-3.67M
631.84%
1.32M
135.88%
163.20M
12,280.16%
67.38M
58.71%
-1.50M
102.23%
13.07M
971.19%
193.85M
1,383.00%
786.95M
305.95%
974.69B
123,757.05%
enterprise value over ebitda
-87.74
-
-0.10
99.88%
0.33
429.80%
-0.14
141.62%
-6.25
4,394.08%
-2.12
66.11%
0.04
101.73%
-0.32
986.13%
-2.44
654.61%
-6.08
148.77%
-3.83K
62,881.40%
ev to operating cash flow
-22.38
-
-0.31
98.61%
0.53
270.62%
-0.18
134.23%
-5.79
3,078.22%
-2.51
56.68%
0.04
101.66%
-0.44
1,154.82%
-3.55
709.12%
-8.39
136.12%
-5.29K
63,007.44%
ev to sales
6.06
-
0.16
97.36%
-1.45
1,005.26%
0.40
127.29%
40.77
10,220.41%
8.03
80.29%
-0.34
104.19%
12.45
3,801.30%
65.42
425.53%
444.10
578.80%
3.10M
698,864.00%
free cash flow per share
-93.50
-
-247.26
164.45%
-195.22
21.04%
-150.41
22.95%
-22.15
85.28%
-13.83
37.56%
-17.30
25.10%
-8.38
51.54%
-4.61
45.04%
-2.95
35.99%
-0.00
99.86%
free cash flow yield
-0.05
-
-0.43
846.40%
-1.16
168.11%
-2.00
72.55%
-0.14
92.93%
-0.30
114.94%
-2.40
689.68%
-0.51
78.79%
-0.23
54.27%
-0.10
56.68%
-0.00
99.81%
graham net net
-40.90
-
391.63
1,057.49%
242.71
38.02%
-17.03
107.02%
26.94
258.19%
24.17
10.28%
5.94
75.41%
32.73
450.61%
15.21
53.52%
11.88
21.89%
0.01
99.92%
graham number
791.27
-
3.25K
311.08%
1.43K
55.97%
200.48
86.00%
118.14
41.07%
98.50
16.62%
58.70
40.41%
153.92
162.23%
48.59
68.43%
32.91
32.27%
0.03
99.90%
income quality
0.54
-
0.28
48.13%
0.61
117.10%
0.57
6.31%
1.06
86.21%
0.82
22.74%
0.86
4.90%
0.27
68.76%
0.69
155.53%
0.72
5.13%
0.77
7.22%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-0.10
-
-6.71
6,617.15%
-79.34
1,081.96%
-131.66
65.95%
-69.27
47.39%
-37.90
45.29%
-50.27
32.66%
-217.28
332.20%
-26.58K
12,131.03%
-276.35
98.96%
137.76
149.85%
interest debt per share
212.15
-
110.01
48.14%
34.65
68.51%
23.70
31.58%
8.03
66.11%
5.66
29.52%
4.37
22.72%
0.27
93.81%
0.04
83.79%
0.18
307.95%
0.00
99.77%
inventory turnover
7.01
-
18.12
158.56%
13.22
27.04%
39.81
201.17%
invested capital
0.34
-
0.01
96.12%
0.11
694.92%
-3.21
3,119.86%
0.26
108.04%
0.20
22.15%
0.53
162.80%
0.00
99.28%
0.00
26.92%
0.01
380.45%
0.05
243.45%
market cap
25.65M
-
5.73M
77.66%
6.05M
5.64%
3.61M
40.29%
200.72M
5,453.61%
89.69M
55.32%
15.04M
83.23%
58.51M
289.01%
235.63M
302.70%
937.27M
297.77%
974.77B
103,901.45%
net current asset value
408.42K
-
4.69M
1,047.58%
9.24M
97.18%
-326K
103.53%
37.90M
11,724.85%
50.57M
33.43%
15.23M
69.88%
118.39M
677.32%
184.17M
55.56%
384.52M
108.79%
438.08M
13.93%
net debt to ebitda
-1.64
-
0.74
145.11%
0.88
19.70%
0.24
72.62%
1.44
493.19%
0.70
51.19%
0.40
42.49%
1.13
179.42%
0.53
53.22%
1.16
120.49%
0.32
72.05%
net income per share
-172.21
-
-786.95
356.98%
-314.98
59.97%
-263.53
16.34%
-20.66
92.16%
-16.57
19.80%
-20.31
22.53%
-31.20
53.66%
-6.66
78.64%
-3.91
41.33%
-0.01
99.86%
operating cash flow per share
-93.12
-
-220.73
137.04%
-191.80
13.10%
-150.35
21.61%
-21.95
85.40%
-13.60
38.04%
-17.26
26.88%
-8.37
51.49%
-4.58
45.30%
-2.92
36.14%
-0.00
99.86%
payables turnover
6.09
-
12.72
108.81%
10.21
19.68%
16.03
56.88%
receivables turnover
4.34
-
3.97
8.56%
6.44
62.23%
6.37
1.14%
2.75
56.83%
349.42
12,609.23%
41.31
88.18%
6.57
-
17.37
164.43%
research and ddevelopement to revenue
0.02
-
0.07
202.29%
0.39
482.09%
0.27
32.60%
4.90
1,742.14%
3.63
26.00%
7.80
115.01%
26.96
245.61%
19.20
28.78%
56.94
196.57%
508.81
793.61%
return on tangible assets
-0.59
-
-0.98
65.87%
-0.88
9.99%
-2.98
238.93%
-0.51
83.02%
-0.49
2.13%
-1.40
183.53%
-0.85
39.68%
-0.39
53.89%
-0.29
26.04%
-0.48
68.13%
revenue per share
344.19
-
430.88
25.19%
70.57
83.62%
69.38
1.68%
3.12
95.50%
4.25
36.20%
2.14
49.75%
0.30
86.18%
0.25
15.78%
0.06
77.79%
0.00
99.99%
roe
-1.07
-
-1.32
23.58%
-1.09
17.37%
38.88
3,672.68%
-0.69
101.77%
-0.64
7.48%
-2.69
322.75%
-0.92
65.66%
-0.42
54.24%
-0.32
24.95%
-0.54
69.38%
roic
-0.14
-
-1.26
816.94%
-0.97
22.97%
-17.53
1,704.07%
-0.55
96.86%
-0.56
1.37%
-1.77
217.19%
-0.91
48.25%
-0.42
53.83%
-0.32
23.40%
-0.55
70.14%
sales general and administrative to revenue
0.41
-
1.63
293.05%
3.03
86.14%
2.37
21.83%
2.73
15.06%
1.32
51.67%
2.61
98.14%
12.63
383.92%
8.71
31.06%
19.85
127.97%
302.54
1,423.82%
shareholders equity per share
161.59
-
597.55
269.79%
289.46
51.56%
-6.78
102.34%
30.02
542.82%
26.02
13.32%
7.54
71.02%
33.75
347.50%
15.75
53.33%
12.31
21.83%
0.01
99.92%
stock based compensation to revenue
0.99
-
1.19
19.40%
0.63
46.75%
0.60
4.87%
0.44
27.10%
0.89
102.85%
3.47
290.08%
4.88
40.63%
11.15
128.48%
213.92
1,817.90%
tangible asset value
2.03M
-
5.99M
195.63%
10.41M
73.76%
-326K
103.13%
38.51M
11,912.88%
51.34M
33.33%
15.75M
69.32%
120.04M
661.95%
187.72M
56.38%
395.06M
110.46%
442.02M
11.89%
tangible book value per share
161.59
-
597.55
269.79%
289.46
51.56%
-6.78
102.34%
30.02
542.82%
26.02
13.32%
7.54
71.02%
33.75
347.50%
15.75
53.33%
12.31
21.83%
0.01
99.92%
working capital
667.77K
-
4.80M
618.21%
9.27M
93.20%
-326K
103.52%
47.97M
14,815.03%
58.64M
22.23%
19.56M
66.64%
118.94M
508.09%
186.53M
56.83%
391.20M
109.73%
459.84M
17.55%

All numbers in USD (except ratios and percentages)